Mark J. Hoenerhoff
Immunology and Microbiology · University of Michigan
Publications
158
Citations
2,714
Est. group size
—
Recurring co-author estimate
Active years
21
Publishing since 2004
Typically publishes in teams of ~10 · 8% small-team papers (≤3 authors) · across 18 venues
- 56Fe-ion Exposure Increases the Incidence of Lung and Brain Tumors at a Similar Rate in Male and Female Mice
Radiation Research · 2024
- Endocrine System
Elsevier eBooks · 2024
- Pelvic Limb Vessels and Nerves
2024
- Septicemia caused by an emerging pathogen, <i>Elizabethkingia miricola</i> , in a laboratory colony of African dwarf frogs ( <i>Hymenochirus curtipes)</i>
Veterinary Pathology · 2023
- NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast Cancer
Cancers · 2023
- Lethal eosinophilic crystalline pneumonia in mice expressing a stabilized <i>Csf2</i> <scp>mRNA</scp>
The FASEB Journal · 2023
- <sup>56</sup> Fe ion exposure increases the incidence of lung and brain tumors at a similar rate in male and female mice
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast Cancer
Preprints.org · 2023
- Unraveling Tumorigenicity in iPSC-Derived Immune Cells: The Impact of Chromosomal Abnormalities and Proliferative Intermediates
Blood · 2023
- Data from Bmi-1 Cooperates with H-Ras to Transform Human Mammary Epithelial Cells via Dysregulation of Multiple Growth-Regulatory Pathways
2023
- Data from Identification of an Integrated SV40 T/t-Antigen Cancer Signature in Aggressive Human Breast, Prostate, and Lung Carcinomas with Poor Prognosis
2023
- Supplementary Methods from Identification of an Integrated SV40 T/t-Antigen Cancer Signature in Aggressive Human Breast, Prostate, and Lung Carcinomas with Poor Prognosis
2023
- Supplementary Table 4 from Identification of an Integrated SV40 T/t-Antigen Cancer Signature in Aggressive Human Breast, Prostate, and Lung Carcinomas with Poor Prognosis
2023
- Supplementary Methods from Identification of an Integrated SV40 T/t-Antigen Cancer Signature in Aggressive Human Breast, Prostate, and Lung Carcinomas with Poor Prognosis
2023
- Supplementary Figure 2 from Identification of an Integrated SV40 T/t-Antigen Cancer Signature in Aggressive Human Breast, Prostate, and Lung Carcinomas with Poor Prognosis
2023
- Toxicologic Pathology×13
- Elsevier eBooks×6
- Veterinary Pathology×4
- bioRxiv (Cold Spring Harbor Laboratory)×4
- ASAIO Journal×3
- Jay Overholser
Immunology and Microbiology · Indiana University
- Lisha Wang
Immunology and Microbiology · University of Michigan
- Jasdeep S. Kler
Immunology and Microbiology · University of Michigan
- Aki Hoji
Immunology and Microbiology · Indiana University
- Marisa Aikins
Immunology and Microbiology · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile